Home » Authors » Karen Young

Karen Young

Articles

ARTICLES

Infinity Raises $70M To Apply Chemistry Technology To Targets

June 25, 2002

Infinity Raises $70M To Apply Chemistry Technology To Targets

June 25, 2002

AltaRex Changes Course After Licensing Lead Products To UTC

June 24, 2002

AltaRex Changes Course After Licensing Lead Products To UTC

June 24, 2002

Salmedix Raises $27.5M In Series B For Phase II Trials

June 21, 2002

Salmedix Raises $27.5M In Series B For Phase II Trials

June 21, 2002

ViroPharma, Wyeth Lengthen HCV Drug Discovery Agreement

June 20, 2002

ViroPharma, Wyeth Lengthen HCV Drug Discovery Agreement

June 20, 2002

Vical, Centocor Expand Alliance To Develop Cancer DNA Vaccines

June 19, 2002

Vical, Centocor Expand Alliance To Develop Cancer DNA Vaccines

June 19, 2002

View All Articles by Karen Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...